- $46.31m
- $54.64m
- $27.04m
- 34
- 58
- 60
- 49
Annual balance sheet for DarioHealth, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 28.8 | 36 | 49.5 | 37.1 | 28.6 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.62 | 1.71 | 6.9 | 5.18 | 5.06 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 34.1 | 45.6 | 65.5 | 47.3 | 40.5 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.07 | 0.989 | 1.99 | 1.87 | 1.77 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 35.4 | 101 | 119 | 96.4 | 119 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 7.03 | 14.4 | 19.4 | 12.5 | 16.6 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 7.26 | 15.2 | 39.2 | 38.2 | 46.9 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 28.2 | 85.5 | 80 | 58.1 | 72 |
| Total Liabilities & Shareholders' Equity | 35.4 | 101 | 119 | 96.4 | 119 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |